Target
Prolyl hydroxylase EGLN3
Ligand
BDBM477219
Substrate
n/a
Meas. Tech.
EGLN-1 Activity Assay
IC50
99.2±10.2 nM
Citation
 You, QZhang, XLei, YHu, TWu, XSun, HGuo, XXu, X Alkynyl pyridine prolyl hydroxylase inhibitor, and preparation method and medical use thereof US Patent  US10889546 Publication Date 1/12/2021 
Target
Name:
Prolyl hydroxylase EGLN3
Synonyms:
EGLN3 | EGLN3_HUMAN | Egl nine homolog 3 (EGLIN3) | Egl nine homolog 3 (EGLN3)
Type:
Protein
Mol. Mass.:
27265.54
Organism:
Homo sapiens (Human)
Description:
Q9H6Z9
Residue:
239
Sequence:
MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED
  
Inhibitor
Name:
BDBM477219
Synonyms:
US10889546, Example 28
Type:
Small organic molecule
Emp. Form.:
C17H14ClN3O4
Mol. Mass.:
359.764
SMILES:
NC(=O)CNC(=O)c1ncc(cc1O)C#CCOc1ccc(Cl)cc1
Structure:
Search PDB for entries with ligand similarity: